Cargando…

α7 nicotinic acetylcholine receptor agonist attenuates the cerebral injury in a rat model of cardiopulmonary bypass by activating the Akt/GSK3β pathway

α7 nicotinic acetylcholine receptor (α7nAchR) agonist treatment may provide a promising therapeutic effect for cerebral injuries. However, it is unclear whether the activation of α7nAchR agonist may reduce cerebral injuries induced by cardiopulmonary bypass (CPB). A total of 96 male Sprague-Dawley r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yingjie, Song, Dandan, Wang, Mei, Chen, Keyan, Zhang, Tiezheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779879/ https://www.ncbi.nlm.nih.gov/pubmed/28944927 http://dx.doi.org/10.3892/mmr.2017.7600

Ejemplares similares

α7 nicotinic acetylcholine receptor agonist inhibits the damage of rat hippocampal neurons by TLR4/Myd88/NF-κB signaling pathway during cardiopulmonary bypass
por: Chen, Keyan, et al.
Publicado: (2017)

Hydrogen-rich solution against myocardial injury and aquaporin expression via the PI3K/Akt signaling pathway during cardiopulmonary bypass in rats
por: Song, Dandan, et al.
Publicado: (2018)

Hydrogen-rich solution attenuates myocardial injury caused by cardiopulmonary bypass in rats via the Janus-activated kinase 2/signal transducer and activator of transcription 3 signaling pathway
por: Chen, Keyan, et al.
Publicado: (2018)

Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity
por: Galle-Treger, Lauriane, et al.
Publicado: (2016)

Electroacupuncture Pretreatment Attenuates Acute Lung Injury Through α7 Nicotinic Acetylcholine Receptor-Mediated Inhibition of HMGB1 Release in Rats After Cardiopulmonary Bypass
por: Wang, Zhankui, et al.
Publicado: (2018)

A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE
por: Godin, Jean-Rémi, et al.
Publicado: (2019)

The selective α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced inflammation and lung injury
por: Kox, M, et al.
Publicado: (2009)

κ-opioid receptor agonists may alleviate intestinal damage in cardiopulmonary bypass rats by inhibiting the NF-κB/HIF-1α pathway
por: Zhang, Xiaoyan, et al.
Publicado: (2020)

Phosphocholine – an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors
por: Richter, K., et al.
Publicado: (2016)

Effects of TLR3 and TLR9 Signaling Pathway on Brain Protection in Rats Undergoing Sevoflurane Pretreatment during Cardiopulmonary Bypass
por: Nan, Zhou, et al.
Publicado: (2017)

Hypercholesterolemia attenuates cardioprotection of ischemic preconditioning and postconditioning with α7 nicotinic acetylcholine receptor agonist by enhancing inflammation and inhibiting the PI3K/Akt/eNOS pathway
por: Wen, Chao, et al.
Publicado: (2022)

TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors
por: Wall, Teagan R., et al.
Publicado: (2017)

A Selective α7 Nicotinic Acetylcholine Receptor Agonist, PNU-282987, Attenuates ILC2s Activation and Alternaria-Induced Airway Inflammation
por: Yuan, Fang, et al.
Publicado: (2021)

α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates DSS-induced intestinal colitis by improving intestinal mucosal barrier function
por: Ye, Ziping, et al.
Publicado: (2022)

Partial nicotinic acetylcholine (α4β2) agonists as promising new medications for smoking cessation
por: Singh, J., et al.
Publicado: (2008)

Contrasting Properties of α7-Selective Orthosteric and Allosteric Agonists Examined on Native Nicotinic Acetylcholine Receptors
por: Gill, JasKiran K., et al.
Publicado: (2013)

Nicotinic Acetylcholine Receptor Agonists Attenuate Septic Acute Kidney Injury in Mice by Suppressing Inflammation and Proteasome Activity
por: Chatterjee, Prodyot K., et al.
Publicado: (2012)

κ-opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO-1 pathway
por: Fan, Jianing, et al.
Publicado: (2021)

The effective opening of nicotinic acetylcholine receptors with single agonist binding sites
por: Williams, Dustin K., et al.
Publicado: (2011)

Acetylcholine receptors in the retinas of the α7 nicotinic acetylcholine receptor knockout mouse
por: Smith, Marci L., et al.
Publicado: (2014)

Targeting α7 nicotinic acetylcholine receptors for chronic pain
por: Zhou, Ya-Qun, et al.
Publicado: (2022)

Agonist and antagonist effects of tobacco-related nitrosamines on human α4β2 nicotinic acetylcholine receptors
por: Brusco, Simone, et al.
Publicado: (2015)

Differential Modulation of GABA(A) and NMDA Receptors by an α7-nicotinic Acetylcholine Receptor Agonist in Chronic Glaucoma
por: Zhou, Xujiao, et al.
Publicado: (2017)

Inflammation Regulation via an Agonist and Antagonists of α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages
por: Tan, Yao, et al.
Publicado: (2022)

Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
por: Mizrachi, Tehila, et al.
Publicado: (2021)

Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI
por: Deba, Farah, et al.
Publicado: (2021)

Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine
por: Schapira, Matthieu, et al.
Publicado: (2002)

Investigation of the Possible Pharmacologically Active Forms of the Nicotinic Acetylcholine Receptor Agonist Anabaseine
por: Andrud, Kristin, et al.
Publicado: (2019)

Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
por: Alexandris, Nikolaos, et al.
Publicado: (2020)

Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor
por: Spurny, Radovan, et al.
Publicado: (2015)

6-Bromohypaphorine from Marine Nudibranch Mollusk Hermissenda crassicornis is an Agonist of Human α7 Nicotinic Acetylcholine Receptor
por: Kasheverov, Igor E., et al.
Publicado: (2015)

α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 Ameliorates Cognitive Impairment Induced by Chronic Intermittent Hypoxia
por: Shen, Hui, et al.
Publicado: (2021)

The proximal tubular α7 nicotinic acetylcholine receptor attenuates ischemic acute kidney injury through Akt/PKC signaling-mediated HO-1 induction
por: Kim, Hwajin, et al.
Publicado: (2018)

Menthol Binding and Inhibition of α7-Nicotinic Acetylcholine Receptors
por: Ashoor, Abrar, et al.
Publicado: (2013)

Mechanism of calcium potentiation of the α7 nicotinic acetylcholine receptor
por: Natarajan, Kathiresan, et al.
Publicado: (2020)

Role of the α7 Nicotinic Acetylcholine Receptor in the Pathophysiology of Atherosclerosis
por: Vieira-Alves, Ildernandes, et al.
Publicado: (2020)

Peptide Inhibitors of the α-Cobratoxin–Nicotinic Acetylcholine Receptor Interaction
por: Lynagh, Timothy, et al.
Publicado: (2020)

The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation
por: Sitapara, Ravikumar A., et al.
Publicado: (2020)

The New Anthelmintic Tribendimidine is an L-type (Levamisole and Pyrantel) Nicotinic Acetylcholine Receptor Agonist
por: Hu, Yan, et al.
Publicado: (2009)

Selective Ligand Behaviors Provide New Insights into Agonist Activation of Nicotinic Acetylcholine Receptors
por: Marotta, Christopher B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2lt8k9d68hdaudic1m7lmvh57l